MTU Aero Confirms Adjusted Guidance After Pratt & Whitney Jet Engines Recall
By Mauro Orru
MTU Aero Engines backed its adjusted guidance for the year after Pratt & Whitney parent RTX said it would recall hundreds of jet engines for inspection due to suspected contaminated metal in some parts that could lead to cracking.
RTX, previously known as Raytheon Technologies, said Monday that it would remove about 600 to 700 Pratt engines for inspection over the next three years due to the previously disclosed issue related to the powdered metal used to make certain engine parts. MTU supplies key components for Pratt's geared-turbofan engines that power aircraft such as Airbus's A320neo.
Earlier this week, MTU said it was expecting a hit of around EUR1 billion to revenue and reported EBIT after the jet engines recall.
Executives from the German aircraft-engine manufacturer said during a call Wednesday that the group is still targeting revenue between EUR6.1 billion and EUR6.3 billion this year, though the forecast is still subject to adjustments. Adjusted earnings before interest and taxes--a key profitability metric for MTU--should come in slightly higher than EUR800 million.
"The financial burdens arising from the geared turbofan inspection program are undoubtedly present, but they are not likely to be reflected in the adjusted guidance figures," said Chief Executive Lars Wagner.
The company also backed its 2025 outlook, projecting a steady rise in revenue to around EUR8 billion and adjusted EBIT of around EUR1 billion.
"We are working intensively to minimize the inspection program's impact on our customers," Wagner said.
Write to Mauro Orru at mauro.orru@wsj.com; @MauroOrru94
(END) Dow Jones Newswires
September 13, 2023 11:11 ET (15:11 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth